TVGN

Tevogen Bio Holdings Inc. (TVGN) is a pioneering clinical-stage biotechnology company based in Warren, New Jersey, specializing in the development of off-the-shelf precision T cell therapeutics aimed at addressing significant unmet medical needs across virology, oncology, and neurology. By utilizing innovative immunotherapy techniques, Tevogen Bio seeks to redefine treatment paradigms and enhance patient outcomes through greater accessibility to state-of-the-art therapies. With a strong emphasis on harnessing the potential of the immune system, the company is positioned to be a frontrunner in the rapidly evolving field of targeted therapeutics, offering promising solutions to some of healthcare's most critical challenges.